ACADIA Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
ACADIA Pharmaceuticals has a total shareholder equity of $516.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $914.1M and $397.4M respectively. ACADIA Pharmaceuticals's EBIT is $22.8M making its interest coverage ratio -1.1. It has cash and short-term investments of $500.9M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -1.1x |
Cash | US$500.94m |
Equity | US$516.70m |
Total liabilities | US$397.40m |
Total assets | US$914.10m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DR6's short term assets ($728.9M) exceed its short term liabilities ($337.9M).
Long Term Liabilities: DR6's short term assets ($728.9M) exceed its long term liabilities ($59.5M).
Debt to Equity History and Analysis
Debt Level: DR6 is debt free.
Reducing Debt: DR6 has not had any debt for past 5 years.
Debt Coverage: DR6 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: DR6 has no debt, therefore coverage of interest payments is not a concern.